Tao Y - Search Results

1

Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma.

Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M. Vauthey JN, et al. Among authors: tao y. Am J Surg. 1995 Jan;169(1):28-34; discussion 34-5. doi: 10.1016/s0002-9610(99)80106-8. Am J Surg. 1995. PMID: 7817995

2

Pain as a predictor of outcome in patients with operable pancreatic carcinoma.

Kelsen DP, Portenoy R, Thaler H, Tao Y, Brennan M. Kelsen DP, et al. Among authors: tao y. Surgery. 1997 Jul;122(1):53-9. doi: 10.1016/s0039-6060(97)90264-6. Surgery. 1997. PMID: 9225915

3

Pain and depression in patients with newly diagnosed pancreas cancer.

Kelsen DP, Portenoy RK, Thaler HT, Niedzwiecki D, Passik SD, Tao Y, Banks W, Brennan MF, Foley KM. Kelsen DP, et al. Among authors: tao y. J Clin Oncol. 1995 Mar;13(3):748-55. doi: 10.1200/JCO.1995.13.3.748. J Clin Oncol. 1995. PMID: 7884435

4

Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis.

Sirott MN, Bajorin DF, Wong GY, Tao Y, Chapman PB, Templeton MA, Houghton AN. Sirott MN, et al. Among authors: tao y. Cancer. 1993 Nov 15;72(10):3091-8. doi: 10.1002/1097-0142(19931115)72:10<3091::aid-cncr2820721034>3.0.co;2-v. Cancer. 1993. PMID: 8221576

5

Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.

Kemeny N, Cohen A, Seiter K, Conti JA, Sigurdson ER, Tao Y, Niedzwiecki D, Botet J, Budd A. Kemeny N, et al. Among authors: tao y. J Clin Oncol. 1993 Feb;11(2):330-5. doi: 10.1200/JCO.1993.11.2.330. J Clin Oncol. 1993. PMID: 8426211 Clinical Trial.

6

A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.

Kelsen DP, Saltz L, Cohen AM, Yao TJ, Enker W, Tong W, Tao Y, Bertino JR. Kelsen DP, et al. Among authors: tao y. Cancer. 1994 Oct 15;74(8):2224-33. doi: 10.1002/1097-0142(19941015)74:8<2224::aid-cncr2820740804>3.0.co;2-a. Cancer. 1994. PMID: 7922973 Clinical Trial.

7

Effect of relative cumulative dose-intensity on survival of patients with urothelial cancer treated with M-VAC.

Scher HI, Geller NL, Curley T, Tao Y. Scher HI, et al. Among authors: tao y. J Clin Oncol. 1993 Mar;11(3):400-7. doi: 10.1200/JCO.1993.11.3.400. J Clin Oncol. 1993. PMID: 8445414

8

Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors.

Saltz L, Trochanowski B, Buckley M, Heffernan B, Niedzwiecki D, Tao Y, Kelsen D. Saltz L, et al. Among authors: tao y. Cancer. 1993 Jul 1;72(1):244-8. doi: 10.1002/1097-0142(19930701)72:1<244::aid-cncr2820720143>3.0.co;2-q. Cancer. 1993. PMID: 8389666 Clinical Trial.

9

Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer.

Seidman AD, Scher HI, Gabrilove JL, Bajorin DF, Motzer RJ, O'Dell M, Curley T, Dershaw DD, Quinlivan S, Tao Y, et al. Seidman AD, et al. Among authors: tao y. J Clin Oncol. 1993 Mar;11(3):408-14. doi: 10.1200/JCO.1993.11.3.408. J Clin Oncol. 1993. PMID: 7680373 Clinical Trial.

10

A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistance.

Saltz L, Murphy B, Kemeny N, Bertino J, Tong W, Keefe D, Tzy-Jun Y, Tao Y, Kelsen D, O'Brien JP. Saltz L, et al. Among authors: tao y. Cancer. 1994 Nov 15;74(10):2757-64. doi: 10.1002/1097-0142(19941115)74:10<2757::aid-cncr2820741004>3.0.co;2-o. Cancer. 1994. PMID: 7954234 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,985 results

Search Page

Filters